1 - 25 of 91 Items

Review paper2022, mar 29

Systemic juvenile idiopathic arthritis — current diagnostic and therapeutic management

Elżbieta Barbara Smolewska, Violetta Opoka-Winiarska, Zbigniew Żuber

Vol 7, No 4 (2021)

Review paper

Rheumatol. Forum 2021;7(4):145-154.
Review paper2022, mar 29

Scales for the assessment of children with rheumatic diseases

Roksana Malak, Włodzimierz Samborski

Vol 7, No 4 (2021)

Review paper

Rheumatol. Forum 2021;7(4):177-182.
Review paper2022, mar 29

Ocular lesions in Behçet’s disease

Grzegorz Chmielewski, Jakub Kuna, Magdalena Krajewska-Włodarczyk

Vol 7, No 4 (2021)

Review paper

Rheumatol. Forum 2021;7(4):165-168.
Review paper2022, mar 29

COVID-19 vaccination in patients with rheumatic diseases — status February 2022

Violetta Opoka-Winiarska, Elżbieta Smolewska

Vol 7, No 4 (2021)

Review paper

Rheumatol. Forum 2021;7(4):155-164.
Review paper2022, mar 29

Immune-mediated inflammatory disease patients in the era of COVID-19 — who, how and when to vaccinate against COVID-19

Olga Gumkowska-Sroka, Karolina Nowak, Przemysław Kotyla

Vol 7, No 4 (2021)

Review paper

Rheumatol. Forum 2021;7(4):169-176.
Review paper2022, jun 17

Fibromyalgia — new horizons

Edyta Prokop-Przybył, Przemysław Keczmer, Włodzimierz Samborski

Vol 8, No 1 (2022)

Review paper

Rheumatology Forum 2022;8(1):27-30.
Case report2022, jun 17
Case report2022, jun 23

New-onset psoriasis after rituximab for the treatment of granulomatosis with polyangiitis: A case report and review of the literature

Tacjana Barczyńska, Bernadetta Helena Paszkowska, Małgorzata Węgierska, Joanna Zalewska, Sławomir Jeka

Vol 8, No 2 (2022)

Case report

Rheumatology Forum 2022;8(2):91-93.
Guidelines / Expert consensus2022, jun 22

Cardiological and rheumatological expert statement on the management of asymptomatic hyperuricemia in patients at high cardiovascular risk

Marcin Barylski, Bogdan Batko, Krzysztof J. Filipiak, Artur Mamcarz, Maria Rell-Bakalarska, Włodzimierz Samborski, Piotr Wiland

Vol 8, No 2 (2022)

Guidelines / Expert consensus

Rheumatology Forum 2022;8(2):43-59.
Review paper2022, jun 23

Difficulties in the diagnosis of antisynthetase syndrome

Aleksandra Opinc, Joanna Makowska

Vol 8, No 2 (2022)

Review paper

Rheumatology Forum 2022;8(2):84-90.
Letter to the Editor2022, mar 29

Professor dr hab. Andrzej Nowakowski — a supporter of Poznań rheumatology

Włodzimierz Samborski

Vol 7, No 4 (2021)

Letter to the Editor

Rheumatol. Forum 2021;7(4):191-193.
Review paper2022, jun 17

Recommendations for the use of imaging and management of osteoarthritis in the light of current guidelines

Anna Kwaśniewska, Magdalena Chudala, Wojciech Romanowski

Vol 8, No 1 (2022)

Review paper

Rheumatology Forum 2022;8(1):1-5.
Review paper2022, sep 30

Gout in the course of systemic lupus erythematosus: Literature review and case study report

Izabela Ptak, Bogna Grygiel-Górniak, Włodzimierz Samborski

Vol 8, No 3 (2022)

Review paper

Rheumatology Forum 2022;8(3):105-110.
Research paper2022, jun 23

Analysis of hospital admissions of rheumatoid arthritis patients in the context of everyday clinical practice

Karolina Nowak, Olga Gumkowska-Sroka, Przemysław Kotyla

Vol 8, No 2 (2022)

Research paper

Rheumatology Forum 2022;8(2):60-68.
Research paper2022, jun 17

The use of selected parameters of the mini-golf game for screening the motor assessment of children for Developmental Coordination Disorder — preliminary report

Kinga Litwin, Anna Kostiukow, Piotr Poniewierski, Dominika Janowska, Karolina Biel, Włodzimierz Samborski

Vol 8, No 1 (2022)

Research paper

Rheumatology Forum 2022;8(1):14-26.
Review paper2022, jun 23

Risk of cancers in polymyositis and dermatomyositis

Bogna Grygiel-Górniak, Jakub Soska, Włodzimierz Samborski

Vol 8, No 2 (2022)

Review paper

Rheumatology Forum 2022;8(2):69-76.
Guidelines / Expert consensus2022, jun 17
Review paper2022, sep 30

Antidiabetic effect of disease-modifying antirheumatic drugs

Bożena Targońska-Stępniak

Vol 8, No 3 (2022)

Review paper

Rheumatology Forum 2022;8(3):122-128.
Review paper2022, jun 23

Interstitial lung disease in the course of systemic connective tissue diseases: A common problem for rheumatologists and pulmonologists

Zuzanna Gogulska, Żaneta Smoleńska, Amelia Szymanowska-Narloch, Zbigniew Zdrojewski

Vol 8, No 2 (2022)

Review paper

Rheumatology Forum 2022;8(2):77-83.
Review paper2022, sep 30

Autoimmune disorders and thyroid function in patients with rheumatoid arthritis after biological treatment

Nadia Sawicka-Gutaj, Dominika Wietrzyk, Natalia Zawalna, Abikasinee Erampamoorthy, Marek Ruchała

Vol 8, No 3 (2022)

Review paper

Rheumatology Forum 2022;8(3):111-121.
Case report2022, sep 30

Wrist arthroplasty, good alternative for rheumatoid wrist: Case report with literature review

Maciej Grzegorz Bręborowicz, Leszek Kaczmarek, Ewa Bręborowicz, Leszek Romanowski

Vol 8, No 3 (2022)

Case report

Rheumatology Forum 2022;8(3):129-134.
Review paper2022, sep 30

Rheumatic manifestations in cancer patients treated with immune checkpoint inhibitors

Paulina Janiak, Żaneta Smoleńska, Zbigniew Zdrojewski

Vol 8, No 3 (2022)

Review paper

Rheumatology Forum 2022;8(3):98-104.
Letter to the Editor2022, sep 30

History of rheumatology. Foundation of the Polish Society for Rheumatology

Eugeniusz Józef Kucharz

Vol 8, No 3 (2022)

Letter to the Editor

Rheumatology Forum 2022;8(3):140-143.
Editorial2022, sep 30

What does immunology say to rheumatologists that it does not say to others?

Przemyslaw Kotyla, Włodzimierz Samborski

Vol 8, No 3 (2022)

Editorial

Rheumatology Forum 2022;8(3):95-97.